Pulsenmore Ltd. PLSM

Annual Quarterly

FY2025 · ended Dec 31, 2025 · Revenue $12.55M · Filed Mar 30, 2026

Pulsenmore Ltd. (PLSM) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $12.5 million and a net loss of $5.0 million. Free cash flow was -$10.3 million. As of Dec 31, 2025 it held $6.8 million in cash and investments and $491,000 in total debt.

Revenue
$12.55M
Net income
$-4.97M
Operating cash flow
$-10.31M
Free cash flow
$-10.35M
EPS
$0.77
Dividend per share
None
Shares outstanding
6.50M
Net cash
$6.28M
FY 2025
Operating margin
—

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
PLSM (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Israel
Headquarters
Israel
SEC filer status
Non-accelerated filer, Emerging growth company
SEC CIK
2064764

Other Surgical & Medical Instruments & Apparatus companies

All 151 Surgical & Medical Instruments & Apparatus companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

FY 2025
Dec 31, 2025
Revenue
$12.5M
Net income
-$5.0M
Diluted EPS
$0.77
Operating cash flow
-$10.3M
Free cash flow
-$10.3M
Total assets
$31.9M
Total liabilities
$5.9M
Stockholders' equity
$26.0M
Cash and investments
$6.8M
Total debt
$491,000

Recent SEC filings

Form Description Filed Period
6-K Current report (foreign issuer) Oct 13, 2026 Oct 13, 2026
6-K Current report (foreign issuer) Sep 17, 2026 Sep 17, 2026
6-K Current report (foreign issuer) Sep 8, 2026 Sep 8, 2026
6-K Current report (foreign issuer) Aug 31, 2026 Jun 30, 2026
6-K Current report (foreign issuer) Aug 19, 2026 Aug 19, 2026
6-K Current report (foreign issuer) Aug 17, 2026 Aug 17, 2026

All 52 Pulsenmore Ltd. SEC filings

Source: SEC EDGAR filings. This is company-reported data, not investment advice.